Real-time enrollment status for this large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:34 AM UTC
| NCT Number | NCT06500273 |
| Recruiting Status | Recruiting |
| Condition | Large B-cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 250 participants |
| Active Locations | 50 sites in the US |
| Sponsor | Allogene Therapeutics |
| Last Updated on CT.gov | January 29, 2026 (Jan 29, 2026) |
As of March 2, 2026: Clinical trial NCT06500273 is currently recruiting participants. This clinical trial study for large b-cell lymphoma is actively seeking new participants at 50 locations across the United States. The study is sponsored by Allogene Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06500273 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06500273 was last updated Jan 29, 2026 (January 29, 2026). HelloStudys verifies this status automatically.